Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia

Summary

The purpose of this study is to determine in women the risk/benefit profile and non-inferiority of a topical 5% Minoxidil foam formulation applied once daily for the treatment of androgenetic alopecia in comparison to 2% MTS used twice daily, using objective and subjective efficacy measures and safety assessments for a study period of 24 weeks.

Timeline

Start

2008-06

Primary completion

2009-02

Completion

2009-06

Drugs

Indications